WHO ICTRP trial
A 12-WEEK PROOF OF CONCEPT STUDY FOR PF-04991532 IN T2DM SUBJECTS.
EUCTR2011-000602-22-SK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2011-000602-22-SK |
|---|---|
| Public title | A 12-WEEK PROOF OF CONCEPT STUDY FOR PF-04991532 IN T2DM SUBJECTS. |
| Scientific title | A 12-WEEK, PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, DOSE-RANGING, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ONCE DAILY PF-04991532 AND SITAGLIPTIN IN ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED ON METFORMIN |
| Primary sponsor | Pfizer Inc |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Serbia;Hungary;Taiwan;Mexico;Slovakia;Korea, Democratic People's Republic of;Bulgaria;India |
| Conditions | Type 2 Diabetes Mellitus MedDRA version: 13.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and… |
| Interventions | Product Name: Not Applicable Product Code: PF-04991532 Pharmaceutical Form: Tablet INN or Proposed INN: Not Applicable Current Sponsor code: PF-04991532 Other descriptive name: Not Applicable Concentration unit: mg milligram(s)… |
| Registration date | May 26, 2011 |
| Target size | 240 |
| Secondary IDs | B2611002 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: